MoonLake Immunotherapeutics
MLTX
#3647
Rank
$2.67 B
Marketcap
$42.49
Share price
0.57%
Change (1 day)
99.48%
Change (1 year)

Revenue for MoonLake Immunotherapeutics (MLTX)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MoonLake Immunotherapeutics from 2022 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)N/A
2022N/A